Novartis has called off the sale of two US generics businesses to India’s Aurobindo Pharma, part of a restructuring of the Swiss big pharma as it concentrates more effort on higher-margin, innovative ...
Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results